Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
179.29
+0.36 (0.20%)
At close: Aug 22, 2025, 4:00 PM
179.28
-0.01 (-0.01%)
After-hours: Aug 22, 2025, 7:52 PM EDT
Johnson & Johnson Market Cap
Johnson & Johnson has a market cap or net worth of $431.79 billion as of August 22, 2025. Its market cap has increased by 12.88% in one year.
Market Cap
431.79B
Enterprise Value
463.67B
1-Year Change
12.88%
Ranking
Category
Stock Price
$179.29
Market Cap Chart
Since May 14, 2001, Johnson & Johnson's market cap has increased from $136.61B to $431.79B, an increase of 216.08%. That is a compound annual growth rate of 4.85%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 22, 2025 | 431.79B | 24.01% |
Dec 31, 2024 | 348.19B | -7.72% |
Dec 29, 2023 | 377.32B | -18.30% |
Dec 30, 2022 | 461.85B | 2.55% |
Dec 31, 2021 | 450.36B | 8.70% |
Dec 31, 2020 | 414.31B | 7.92% |
Dec 31, 2019 | 383.91B | 10.92% |
Dec 31, 2018 | 346.11B | -7.79% |
Dec 29, 2017 | 375.36B | 19.76% |
Dec 30, 2016 | 313.43B | 10.28% |
Dec 31, 2015 | 284.22B | -2.90% |
Dec 31, 2014 | 292.70B | 13.27% |
Dec 31, 2013 | 258.42B | 33.02% |
Dec 31, 2012 | 194.27B | 8.47% |
Dec 30, 2011 | 179.09B | 5.44% |
Dec 31, 2010 | 169.86B | -4.42% |
Dec 31, 2009 | 177.71B | 7.05% |
Dec 31, 2008 | 166.00B | -13.03% |
Dec 31, 2007 | 190.88B | -0.28% |
Dec 29, 2006 | 191.42B | 7.06% |
Dec 30, 2005 | 178.79B | -5.00% |
Dec 31, 2004 | 188.21B | 22.75% |
Dec 31, 2003 | 153.33B | -3.90% |
Dec 31, 2002 | 159.55B | -11.43% |
Dec 31, 2001 | 180.14B | 31.87% |
View and export this data all the way back to 2001. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 641.16B |
AbbVie | 373.29B |
UnitedHealth Group | 276.23B |
AstraZeneca | 250.11B |
Novartis AG | 246.48B |
Novo Nordisk | 239.90B |
Abbott Laboratories | 231.74B |
Merck & Co. | 217.01B |